Sort   by:  
 Page size 
UnknownInhibitors of the Detoxifying Enzyme of the Phytoalexin Brassinin Based on Quinoline and Isoquinoline Scaffolds.
Not available
S-EPMC6152025 | biostudies-literature
UnknownDose-response relationship between cumulative physical workload and osteoarthritis of the hip - a meta-analysis applying an external reference population for exposure assignment.
Not available
S-EPMC5984732 | biostudies-literature
UnknownSelective enzymatic esterification of lignin model compounds in the ball mill.
Not available
S-EPMC5588541 | biostudies-literature
UnknownFormation of Racemic Phases of Amino Acids by Liquid-Assisted Resonant Acoustic Mixing Monitored by Solid-State NMR Spectroscopy.
Not available
S-EPMC12472410 | biostudies-literature
UnknownNovel Broccoli Sulforaphane-Based Analogues Inhibit the Progression of Pancreatic Cancer without Side Effects.
Not available
S-EPMC7277136 | biostudies-literature
UnknownA simple nomogram for early postoperative risk prediction of clinically relevant pancreatic fistula after pancreatoduodenectomy.
Not available
S-EPMC8578094 | biostudies-literature
UnknownMechanochemical Oxidative Degradation of Thienopyridine Containing Drugs: Toward a Simple Tool for the Prediction of Drug Stability.
Not available
S-EPMC10311657 | biostudies-literature
ProteomicsMolecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
Purpose: Chemotherapy is pivotal in the multimodal treatment of pancreatic cancer patients. In recent years, technical advances have developed experimental methods that unveiled a high degree of inter- and intratumoral heterogeneity in pancreatic cancer. We hypothesized that intratumoral heterogenei...
ORGANISM(S): Homo sapiens (Human) 
2023-09-19 | PXD042256 | Pride
Treatment response Pancreatic cancer Intratumor heterogeneity Chemotherapy Gemcitabine 
ProteomicsCharacterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses
Introduction: Ampullary cancer is a relatively rare entity and usually treated by pancreatoduodenectomy followed by adjuvant therapy. The intestinal subtype is associated with markedly improved prognosis after resection. Only few cell lines are available for in vitro studies of ampullary cancer and ...
ORGANISM(S): Homo sapiens (Human) 
2016-03-14 | PXD002657 | Pride
Ampullary adenocarcinoma Cell invasion Differentiation Pancreatobiliary Cell proliferation Fibroblast Dysplastic Intestinal 
UnknownProtein nanobarcodes enable single-step multiplexed fluorescence imaging.
Not available
S-EPMC10735187 | biostudies-literature
Sort   by:  
 Page size